Introduction
Decreased T-cell cellularity and a skewed TCR repertoire are hallmarks of an immune deficiency commonly observed in old age, as consequence of general infectious diseases and aggressive lymphocyte-depleting therapies for diverse malignancies. [1] [2] [3] [4] The regeneration of a phenotypically and functionally normal T-cell compartment is curtailed for an extended period of time in patients receiving hematopoietic stem cell transplantation (HSCT). [5] [6] [7] This lack in Tcell reconstitution is associated with opportunistic infections, the reactivation of latent viral and parasitic infections, chronic inflammation and autoimmunity. 3, 4 Following cytoablative therapy, the recovery of the T-cell compartment relies on two independent pathways, i.e. the expansion of peripheral T-cells and, alternatively, the de novo production of T-cells in the thymus. 1, 2, [7] [8] [9] [10] The latter assures the generation of a population of naïve T-cells expressing a diverse repertoire of TCR specificities. 5, 7, 8, 10, 11 The extent of thymusdependent T-cell reconstitution correlates directly with thymic size following immune ablation and HSC-derived reconstitution 7, 12 but is inversely related to age and transplant-related toxicities such as graft-versus-host disease (GVHD). 10, [13] [14] [15] [16] [17] The generation of new T-cells of donor origin depends on the migration of hematopoietic precursors to the thymus. Normal thymic T-cell development is in turn contingent on the regular maintenance of the stromal microenvironment. However, age-related thymic involution 18 and injury from radiation 19 , GVHD 20 , chemotherapy 12, 21 or infection 3,4,12,18-23 preclude normal thymopoiesis to occur as they directly affect thymic epithelial cells (TECs). There has been considerable interest in identifying strategies to prevent TEC injury. Recently, robust T-cell lymphopoiesis has been maintained in myeloablated HSCT recipients by pretransplant administration of different factors such as IL-7 24, 25 , androgen antagonists 26 and fibroblast growth factor 7 (Fgf7; a.k.a.
keratinocyte growth factor, KGF) 20, [27] [28] [29] . KGF belongs to the family of the structurally related Fgfs and is a potent epithelial cell mitogen. 27, 30 KGF is expressed under physiological conditions within the thymus both by mesenchymal cells and by T-cells at specific developmental stages. To exert its biological activity, KGF activates the IIIb variant of the FgfR2 receptor (FgfR2IIIb) which is expressed within the thymus exclusively on TECs. 31 Experiments using mice deficient for FgfR2IIIb or the removal of mesenchyme from normal embryos revealed the importance of Fgf signaling during early thymus organogenesis. 32 The post-natal thymic epithelial compartment may continue to require growth regulating signals including possibly endogenous KGF, whose thymic expression is sustained throughout life. 28 Although of considerable therapeutic potential, little is known regarding KGF's mode of action on adult thymopoiesis and the thymic microenvironment. Here we report on the cellular and molecular response of adult TEC to a systemic treatment with recombinant human KGF and how the ensuing changes enhance thymopoiesis.
Materials and methods

Animals
Female C57BL/6 and B6.SJL-Ptprc a Pep3 b /BoyJ (B6.CD45.1; CD45.1 + ) mice were purchased from Charles River (France) and the Jackson Laboratories (Bar Harbor, ME, USA), respectively. Mice were six weeks of age at the time of KGF administration. Animals were kept under specific pathogen-free conditions and in accordance with federal regulations.
[Smad4loxFoxn1Cre]F 1 mice were generated by crossing B6.129Smad4 lox/lox mice (a gift from C. Deng, Bethesda, MD, USA) to B6;D2-Tg(Foxn1-cre) 8Ghr transgenic mice which express the Cre-recombinase in TECs (L.T.J. and G.A.H., manuscript in preparation).
In vivo and in vitro KGF treatment
Mice were injected i.p. 3 days (days 0,1 and 2) with HBSS (Hank's balanced salt solution) or recombinant human KGF (palifermin, generously provided by Amgen Inc., Thousand Oaks, CA) solubilized in HBSS at a dose of 5 mg/kg per day. For in vitro studies, thymic stromal cell preparations taken from E15.5 fetal thymic lobes were cultured for the indicated times in media supplemented with KGF (100 ng/ml) or HBSS (v/v).
Flow cytometry
For flow cytometric analyses and cell purifications, fluorochrome-conjugated or unconjugated moAbs against TCRβ (clone H57-592), CD8 (53-6.7), CD4 (RM4-5), CD3 (145-2C11), CD44 (IM7), CD25 (PC61), CD45 (30-F11), CD45.1 (A20), CD45.2 (104), I-A b (AF6-120.1), CD117
(2B8) and CD127 (A7R34) were used (BD Biosciences, San Diego, CA, USA; eBioscience, San Diego, CA, USA; Caltag Laboratories, Burlingame, CA, USA). To reveal biotinylated moAbs, streptavidin-conjugated Cy5, PerCP, CyChrome, phycoerythrin and APC (Zymed Laboratories, San Francisco, CA, USA, and Caltag) were used. Three-color analyses were performed using a FACSCalibur® (Becton Dickinson, Mountain View, CA). The different medullary (m) and cortical (c) TEC subpopulations were identified in stromal cell preparations by flow cytometry by use of the lectin UEA-1 and antibodies specific for the surface molecule MTS24 (a TEC precursor marker 33, 34 ) and the cytokeratins (K)-5 and K18. 20, [35] [36] [37] 
Thymic stromal cell preparations and culture
To generate thymic stromal cell preparations, thymic cell suspensions from adult C57BL/6 mice (6 wk) were digested with collagenase D and DNAse I for three cycles. as described. 33, 38 For quantification, CD45 -I-A b int+high stromal cells present in each cell fraction were counted by flow cytometry. CD45 -I-A b int+high stromal cells were sorted to purity (> 99 %) using a FACSVantage® cell sorter (Becton Dickinson). Thymic stromal cells from fetal (E14.5 or E15.5) C57BL/6 mice were isolated and depleted from lymphoid cells with 2-deoxyguanosine as described 39 ). Purified adult TECs or fetal thymic stromal cells were starved for 24 hours in IMDM/1%FCS, and subsequently stimulated with KGF. Stromal cell proliferation was assessed by 3 H-thymidine incorporation. E15.5 fetal thymic stromal cells were cultured in the presence or absence of the selective IκB kinase inhibitor PS1145 (10 mM, a gift from Millennium, Cambridge, MA, USA), the farnesyltransferase inhibitor L-778,123 (1 mM, Merck Research Laboratories, Rahway, NJ, USA) and the p53 inhibitor PFT102 (10 mM, provided by A.V. Gudkov, Cleveland, OH, USA).
Assessment of TEC proliferation in vivo
Adult C57BL/6 mice (6 wk) were injected i.p. with 5'-bromo-2'-deoxyuridine (BrdU; 1 mg in 0.2 ml PBS; Sigma, Buchs, Switzerland) 48 and 24 hours before sacrifice and analyzed for BrdU incorporation, as described. 40 
Transfer of ETPs
ETPs were purified from adult B6.CD45.1 mice on day 6 after initiation of KGF or HBSS treatment and transferred intrathymically (1000 ETP/lobe) into C57BL/6 (CD45.2 + ) recipients that had received either HBSS or KGF 15 days earlier.
Time-lapse visualization of T-cell precursor attraction
Thymocyte-depleted fetal thymic stromal cell preparations (E14.5) that had been exposed for 24 hours to either KGF (100 ng/ml) or HBSS were co-cultured with T-cell precursors. Cell culture, visualization, reaggregate preparations and data acquisition were carried out as published. 41 For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
Immunohistofluorescence confocal microscopy For analysis of mTEC and cTEC by immunohistology, frozen thymic sections (6 µm) were fixed with 4% paraformaldehyde/PBS and stained with a panel of reagents that was also used for flow cytometry (see above and references 33, 34 ) and the cytokeratins (K)-5 and K18. 20, [35] [36] [37] In addition, moAb against MTS-10 (BD Biosciences) and polyclonal anti-FgfR2IIIb Ab (R&D Systems, Minneapolis, USA) were used. Images were captured on a Zeiss LSM 510 confocal microscope (Carl-Zeiss AG, Feldbach, Switzerland). Overlays of blue (Cy5), red (Alexa555) and green (Alexa488) stainings were colored by computer-assisted management of data using the Zeiss LSM 510 software.
Quantitative PCR cDNA was generated from total RNA and amplified using primers designed for real-time PCR.
Primer sequences for IL-7, GAPDH, Wnt5b, Wnt10b, BMP2, BMP4, CCL21 and CCL25 are available from the authors. RNA transcription levels in TECs from KGF-treated mice or stromal cultures levels were normalized to GAPDH and compared to their expression in HBSStreated control mice or thymic stromal control cultures.
Statistical analysis
Groups were compared by one-way ANOVA and Bonferroni/Dunn post hoc test. The overall statistical significance level was set to 5%. For two-group comparisons, the Mann-Whitney test was applied. StatView TM from SAS Institute Inc. was used for statistical analysis.
Results
KGF increases thymocyte numbers by differentially stimulating cell proliferation
We first determined in adult C57BL/6 mice the consequences of KGF signaling for thymopoiesis. Following treatment for three consecutive days (days 0,1 and 2) with KGF, the total thymic cellularity was transiently diminished (days 4-8) but recovered to higher than normal values on and beyond day 11 ( Figure 1a ). Supranormal numbers of thymocytes were sustained for no less than two months thereafter (data not shown). The increase in total thymocyte cellularity noted beyond day 11 was initially caused by an expansion due to cell proliferation of the most immature, CD3,4,8-triple-negative (TN), thymocytes (Figure 1b-k) . These cells sequentially gave rise to cells with a more mature phenotype. On day 4, the absolute number of all TN thymocytes was comparable for both treatment groups although TN1 and TN2 cells were already increased due to a higher proliferation rate. Over the next few days, TN3 and TN4 followed suit. + thymocytes had been achieved (i.e at day 11 and thereafter). These results demonstrated during steady-state conditions of thymopoiesis a direct correlation between thymic cellularity, the absolute increase in mature thymocytes and the number of recent thymic emigrants.
An increased thymic size in KGF treated mice correlates with enhanced thymic T-cell export
KGF affects numbers and thymic entry of early T-cell precursors
As the absolute number of TN1 cells had increased by 4 days after KGF treatment (Figure 1c ), we investigated whether this effect was due to expansion of the most immature intrathymic cell precursors (early T-cell precursors, ETP). These cells reside within the population of TN1 cells and display a Lin -CD44 + CD25 -CD117 + phenotype. 42, 43 Although the frequency of ETPs was expanded to supra-normal values on day 30, their number was decreased early (i.e. 4 to 11 days) after initiation of KGF treatment ( Figure 3a ). To investigate the cause for this transient reduction, we sought to quantify the attraction and subsequent entry of hematopoietic precursors to the thymus. This was most informatively achieved by time-lapse videomicroscopy of fetal thymic lobes as previously demonstrated by us. 41 Following the exposure of alymphoid E14.5 thymic lobes to KGF, both the number of precursors attracted to and the number of precursors then entering into the lobes were significantly reduced ( Figure 3b ). Several chemokines, including CCL21 and CCL25, have been implicated for the colonization of hematopoietic precursor cells as they are expressed both in the combined fetal thymus/parathyroid anlage and in the postnatal thymus. 41, [44] [45] [46] The exposure of fetal thymic lobes to KGF caused an upregulation of CCL21 but a reduction in CCL25 transcripts ( Figure  3c ). Thus, the decrease in CCL25 correlated with the decreased seeding of T-lymphoid precursors to the thymus.
The effect of KGF on early T-cell precursors is not T-cell-autonomous
The effect of KGF on early thymocyte proliferation may have been driven by the acquisition of a cell-autonomous capacity of TN cells to proliferate better or, alternatively, by an improved thymic stromal microenvironment via the creation of additional developmental niches. We therefore measured the extent of donor-derived thymopoiesis in recipients of intrathymically injected, congenic ETPs. We purified ETPs from B6.CD45.1 donors and intrathymically transferred them to KGF-treated C57BL/6 mice. In a second group, C57BL/6 recipients received ETPs isolated from KGF-treated B6.CD45.1 mice. One week after injection, these mice were compared to a control group where neither donors nor hosts had been treated with KGF. The thymic cellularity was enhanced only under conditions where the C57BL/6 recipient thymic stromal environment had been exposed to KGF (Figure 4a , dashed bar). Here, the absolute numbers of intrathymic CD45.1 + cells (i.e. ETP progeny) was found to be the highest among the three transplantation groups (Figure 4b ). In contrast, ETPs isolated from mice treated with KGF did not exhibit an increased growth rate upon intrathymic transfer into HBSS-injected recipients (open bars). Thus, the treatment with KGF resulted in an improved stromal microenvironment able to increase thymopoiesis but the stroma did not impart on ETPs a cell-autonomous capacity for enhanced reconstitution.
Exogenous KGF is mitogenic for all TEC subpopulations in adult mice
Our data indicated that KGF triggered a temporary deficiency to attract hematopoietic precursor cells but eventually may have created new developmental niches for T-lymphopoiesis or, alternatively, enhanced the ability of TECs to support thymopoiesis. To examine whether KGF differentially acted on the known TEC subpopulations, we first determined in adult C57BL/6 mice the FgfR2IIIb expression among major cortical (K18 Bone morphogenetic proteins play a role in adult TECs in their response to KGF Early TEC development as well as the survival, proliferation, differentiation and migration of thymocytes are under the precise control of different molecules produced by TECs, including Wnt glycoproteins and the bone morphogenetic proteins (BMP)-2 and -4. [47] [48] [49] [50] [51] We therefore tested whether KGF affected the expression of these factors in TECs from adult mice. CD45 -I-A b+ TECs were isolated on day 7 from adult C57BL/6 mice treated with either KGF or HBSS.
As shown in Figure 6a , transcripts for Wnt5b, Wnt10b, BMP2 and BMP4 were up-regulated in vivo by two-to five-fold above normal in response to KGF. To determine a definitive role for BMP-mediated signaling in the TEC response to KGF, we next investigated mice that lacked Smad4 specifically in TECs. Cytoplasmic Smad4 acts as an indispensable partner in the canonical BMP signaling pathway leading to target gene transcription 52 . When compared to B6.129Smad4 lox/lox controls, [Smad4loxFoxn1Cre]F 1 mice displayed a smaller thymus whose cellular composition and architectural organization was proportionally normal (L.T.J. and G.A.H., manuscript in preparation). However, the latter failed to increase their thymic cellularity in response to KGF treatment (Figure 6b ). This deficit was independent of the age of the mouse (data not shown). Hence, the KGF-mediated increase in thymic cellularity was dependent on signals in TECs that engaged Smad4, thus indicating a definitive role of BMPs in the response of thymic epithelium to KGF.
As freshly isolated TECs are not suited to manipulations in vitro due to their rapid loss of TECspecific features, we used E15.5 fetal thymic epithelial cultures to investigate in more detail two important issues related to our findings in adult mice: (i) the regulation in the expression of growth and differentiation factors; and (ii) the signal transduction pathways in TECs activated by KGF. As demonstrated in Figure 7a , the in vitro exposure to KGF (100 ng/ml) robustly increased TEC proliferation. Similar to the results obtained with adult TECs, the exposure of fetal TECs to KGF resulted in an up-regulation of BMP2, BMP4 and Wnt10b (Figure 7b ). The signaling pathways previously shown to mediate KGF activity have included Ras/MAP kinases, phosphatidylinositol 3'kinase (PI3K) and p53. [53] [54] [55] [56] [57] We therefore assessed the effect of KGF on TECs by independently blocking these different signaling pathways ( Figure 7c ). As Wnt molecules provide signals critical for normal TEC development, 49 Wnt10b mRNA expression was used as a quantifiable read-out for our experiments. The blocking of p53 with 58 and that of NF-κB (a downstream target of PI3K) with the IκB kinase inhibitor PS1145, 59 suppressed the upregulation of Wntl0b suggesting that this effect was highly dependent on signaling via both NF-κB and p53. In contrast, using the farnesyltransferase inhibitor L-778,123, 60 the activation of the Ras pathway was not found to be obligatory to mediate the observed KGF effect in fetal TECs.
Discussion
Administration of KGF has been among the therapeutic strategies to promote thymic function. 20, 28 Here we have detailed the molecular and cellular mechanisms by which KGF stimulates thymic T-lymphopoiesis in adult mice. We show that the KGF-specific receptor, FgfR2IIIb, is expressed by both mature cortical and medullary as well as immature TECs ( Figure 5 ). Upon exposure to exogenous KGF, these stromal cells proliferate and express several growth and differentiation factors, including different members of the family of Wnt and BMP molecules (Figures 5,6 ). In consequence, a robust and sustained increase in thymopoiesis occurs which is initiated as a single wave affecting first the most immature T-cell precursors ( Figure 1 ). This effect of enhanced thymopoiesis is uniquely dependent on the exposure of the stromal microenvironment to KGF as the transfer of ETPs from KGF-treated donor mice to naive recipients fails to impart an enhancement in thymopoiesis (Figure 4 ). The increased thymic cellularity leads to an enhanced export of mature T-cells to the periphery (Figure 2 ). Thus, exogenous KGF displays a strong pharmacological activity in the thymus of naïve adult mice which assures a vigorous and enduring increase in thymic T-cell development.
Here we report the normal TEC cellularity of six-week old C57BL/6 mice (3.6 x 10 5 cells; see also reference 61 ) can transiently be expanded by exogenous KGF ( Figure 5 ). In parallel with a higher frequency of mature, i.e. MTS24 -, TECs, the total number of TECs returned at day 15 after initiation of KGF treatment to normal values. These kinetics are consistent with the noted physiological turnover of TECs in adult mice 61, 62 . Due to an increased proliferation rate following KGF stimulation, the resultant TEC expansion has likely an initial but nonetheless decisive impact on lymphoid cellularity after day 11. It is conceivable that enhanced TEC numbers create a "larger" microenvironment able to accommodate increased amounts of early stage thymocytes. Due to the time required for the transition from TN1 to mature thymocytes, [63] [64] [65] an appreciable increase in total thymocyte cellularity secondary to quantitative TEC changes may only be noted after such a maturational progression has occurred, i.e. after about 13. With respect to our results at and beyond day 15, we would argue for a qualitative rather than a quantitative change in the ability of TECs to support thymopoiesis. Such an interpretation is in keeping with Wnt data shown in Figure 6a , the reported role of Wnts in thymopoiesis [66] [67] [68] and the changes in the ratio of MTS24 + to MTS24 -TECs.
The stromal response to KGF allowed for an early and sequential increase in TN thymocytes (Figure 1) 71 Thus, the increase in thymic size together with a restoration of the different thymocyte subpopulations in a proportionally correct fashion reflect the establishment of a regular thymic homeostasis four weeks after treatment with KGF.
As the thymus does not contain hematopoietic stem cells with an unlimited self-renewal capacity, T-cell progenitors need to be recruited from the blood to maintain thymopoiesis. Several mechanisms may account for the decrease in ETPs following the treatment with KGF, including the possibility that KGF affects the number of T-cell precursors homing to the thymus. The necessary steps in the homing process are initiated in vessels at the corticomedullary junction and involve not only the expression of different adhesion molecules on endothelial cells but also the presence of different chemokines 41, 44, 46, 72 Recent data suggests that CCL25 controls the seeding of hematopoietic precursors to both fetal non-vascularized as well as adult thymic tissue. 46, 73 The exposure of the thymic microenvironment to KGF not only decreased the attraction of T-cell precursors to the thymus but also reduced their entry. This fact was correlated with a decrease in CCL25 expression by the fetal thymic microenvironment exposed to KGF. A causal link between these two findings is possible because age-matched embryos deficient for CCL25 display a considerable decrease in thymocyte numbers 44 and the use of neutralizing antibodies against CCL25 in adult mice decreases the thymic accumulation of T-cell precursors. 46 Thus, the down-regulation of CCL25 expression by TECs exposed to KGF may, at least partly, account for the observed paucity of ETPs present early after treatment.
In addition to a phase during which the thymus may have been partially inaccessible for bloodborne T-cell precursors, changes in the kinetics of early thymocyte development could further affect the thymic entry of precursors and/or their developmental expansion in KGF-treated mice. It appears that thymic size is controlled by the number of TN thymocytes which in turn depends on the availability of developmental niches. 69 In KGF-treated mice, TN1 and TN2 cells were indeed significantly increased as early as day 4 after the initiation of KGF treatment and displayed a notably higher proliferation rate when compared to the same cell populations in control mice. Yet, all TN subpopulations and their proliferative responses returned to normal values within two weeks after initiation of KGF treatment. At this point, the number of CD4 + CD8 + thymocytes had increased above the values noted in control animals. However, the kinetics of the changes in the number of TN thymocytes in response to KGF (Figure 1 ) was in keeping with the time reported that TN cells require to transit to CD4 + CD8 + thymocytes [63] [64] [65] and hence excludes a decrease in the TN transition time as an explanation for the observed increase in cellularity. Our findings however suggest that the early and sequential increase in the different TN subpopulations was caused by a single developmental wave initiated by ETPs or their immediate progeny. Beyond day 15 after KGF treatment, increased and proportionally normal thymopoiesis was present for an extended period of time.
The KGF-mediated stimulation of fetal and adult TECs enhanced BMP2 and BMP4 transcripts. Induction of BMP4 expression is consistent with comparable findings in tracheal epithelium cultures exposed to either KGF or Fgf10 which binds also to FgfR2IIIb. It is likely but not formally demonstrated by our experiments that enhancement of BMP2/4 mediated the increase in thymic cellularity as Smad4 -/-mice failed to expand their thymocyte numbers in response to KGF. Normal thymic cellularity is indeed dependent on the correct BMP dose as mice either transgenic for the BMP antagonist, noggin, or deficient for the BMP4 inhibitor, twisted gastrulation, display a reduced thymic size secondary to microenvironmental changes. 50, 74 Even though our results demonstrated an increase in BMP-2/-4 transcripts as a consequence of KGF signaling, a previous report had placed the effect of BMP4 on TECs upstream of KGF/Fgf10. 51 This discrepancy is likely explained by differences in the experimental design as the latter study investigated the effects of BMP4 on thymocyte development while our analysis examined the immediate transcriptional changes in TECs upon KGF signaling. However, it is also conceivable that KGF/Fgf10 are part of a positive feed-back loop regulating BMP4 signaling in TECs.
KGF treatment of TECs also enhanced Wnt expression, albeit at different magnitudes when comparing fetal and adult cells (Figures 6 and 7) . This divergence most likely reflects differences in maturation and thus function. Wnt molecules exert a profound effect on TECs (S. Zuklys, M. Keller and G.A. Holländer, manuscript in preparation, and reference 49 We used
Wnt10b as a read-out in primary TECs and have established a link between KGF signaling and
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From the activation of the PI3K/Akt/NF-κB and the p53 pathways. Stimulation of the PI3K/Akt/NF-κB pathway constitutes a typical feature of KGF signaling in some epithelial cells but the activation of the p53 pathway has not yet been linked to KGF signaling. 56, 57 A functional link between the PI3K/Akt/NF-κB and the p53 pathways may occur indirectly since Akt can modulate p53 activity via a positive feed-back loop thus coordinating p53 activity with other signaling events including the Wnt pathway 75, 76 . Activation of the Ras/MAP kinase pathway was not required for the KGF-mediated up-regulation of Wnt10b. This finding was unexpected as Fgf signaling typically leads to the phosphorylation of the docking protein FRS2α and the recruitment of multiple Grb2/Sos complexes which eventually results in the activation of the Ras/MAP kinase pathway. 53, 54 KGF may elicit differential effects in TECs whereby only some but not others necessitate the activation of the Ras/MAP kinase pathway.
Taken together, the exposure of TECs to KGF has revealed three specific aspects. Firstly, KGF enhances in fetal and adult TECs the expression of growth and differentiation factors previously demonstrated to affect TEC biology. In consequence, a transiently enlarged but regularly structured thymic microenvironment is generated able to impart enhanced T-cell production. Secondly, the exposure of the thymic microenvironment to KGF decreased the expression of the chemokine CCL25 in TECs and thus may have affected the homing of T-cell precursors. This effect was, however, temporary and a proportionally normal representation of the different thymocyte subpopulations was re-established within 4 weeks after the start of treatment. Thirdly, KGF caused changes in the stroma's ability to support separate phases in thymocyte maturation. While these changes allowed for an early and sequentially correct expansion of the TN thymocytes, the immediate consequences of the KGF treatment precluded in parallel a simultaneous increase in CD4 + CD8 + and mature single-positive thymocytes.
Transient alterations in the number, function and/or composition of niches specific for the development and selection of more mature thymocytes could account for this finding. Thus, the treatment of naïve mice with KGF may serve as an informative model to assess the molecular regulation of distinct microenvironmental niches necessary for mouse T-cell development.
KGF-induced thymopoiesis resulted in enhanced export of mature thymic T-cells to the periphery. As there is no evidence that the thymus senses peripheral lymphopenia and gauges its T-cell export accordingly and as changes in thymic output will contribute to the replenishment of the peripheral T-cell compartment, any increase in thymopoiesis may therefore be beneficial for individuals with lymphopenia. The enhanced thymic export of naïve T-cells will also secure a diverse T-cell repertoire as it will concurrently offset the homeostatic expansion of a limited number of mature T-cells. Hence, the use of KGF in clinical medicine may produce an efficient restoration of the T-cell compartment and thus the competence for an effective adaptive immune response.
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